Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, June 24 at 2:00 PM EDT

Register Free →

Radiopharmaceutical Supply and Delivery

Active
Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

This contract involves the supply and delivery of diagnostic and therapeutic radiopharmaceuticals specifically for nuclear medicine services at a Department of Veterans Affairs facility. The radiopharmaceuticals must comply with Nuclear Regulatory Commission (NRC) regulations to ensure safety and regulatory standards are met. A critical requirement of this contract is the rapid delivery of these materials to maintain their clinical usability, highlighting the need for timely and efficient logistics given the time-sensitive nature of these products. The contract is categorized as a subcontract under the NAICS code 325412, which pertains to pharmaceutical preparation manufacturing. It was posted on May 29, 2026, by the 256-NETWORK Contract Office 16 (36C256) of the Department of Veterans Affairs. Although specific details such as the place of performance, point of contact, and set-aside information are not provided, the contract clearly emphasizes maintaining compliance with regulatory standards and ensuring the timely provision of critical radiopharmaceuticals to support patient care within the VA healthcare system.

General Info

Supply and timely delivery of NRC-compliant radiopharmaceuticals for VA nuclear medicine services.

Agency

Department Of Veterans Affairs → 256-NETWORK Contract Office 16 (36C256)

NAICS

325412 - Pharmaceutical Preparation Manufacturing View NAICS

Place of Performance

MS

Set-Aside

NONE

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

Posted

subcontract

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Veterans Affairs → 256-NETWORK Contract Office 16 (36C256)
ContactsNo contacts available
OfficeN/A
Organization / Agency
Department Of Veterans Affairs → 256-NETWORK Contract Office 16 (36C256)
Office AddressN/A
ContactsNo contact information available

Full Description

Show more
Supply of diagnostic and therapeutic radiopharmaceuticals for nuclear medicine services at the VA facility, requiring NRC compliance and rapid delivery to maintain clinical usability.

Similar Contracts

NAICS: 325412
New
Federal
6505--Dutasteride CapsulesThe Department of Veterans Affairs National Acquisition Center plans to issue a Request for Proposal (RFP 36E79726R0029) for the procurement of Dutasteride Capsules to serve multiple federal agencies, including the VA, Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Center. This unrestricted contract aims to secure a reliable supply source for Dutasteride 0.5MG capsules in both 30-count and 90-count bottles, with annual estimated usage of approximately 3,912 and 25,502 bottles respectively. The contract will be awarded to a single responsible offeror who can provide an uninterrupted supply and will have a one-year base period followed by four one-year option periods. Distribution will be managed through the VA and DoD Pharmaceutical Prime Vendor Programs. Offerors must supply the drug under the exact name on the label, with a unique National Drug Code (NDC) exclusive to the offeror. The contractor’s label must be the sole label on the product, with VA labels designed to adhere securely on top without obscuring important information such as barcodes, expiration dates, and lot numbers. Packaging requirements include safety caps that meet specific design criteria with a minimum bottle volume of 120cc and cylindrical shape to accommodate appropriate labeling sizes. The solicitation will be released in a commercial item format in accordance with FAR Part 12 around June 22, 2026, with proposals due by July 7, 2026. Interested parties should monitor SAM.gov for updates and submit offers electronically; efforts to obtain paper copies will not be accommodated. The contract specialist and primary point of contact for this procurement is Richard Mahario.
Nac Pharmaceuticals (36E797)

POSTED

about 24 hours ago

DEADLINE

in 21 days
View Details